Citadel Advisors’s Compugen CGEN Stock Holding History

Citadel Advisors’s Portfolio CGEN Stock Details CGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$239K	Sell	112,393 -44,722	-28%	-$86.8K	﹤0.01%	11013
2025 Q4	$240K	Sell	157,115 -26,873	-15%	-$44.6K	﹤0.01%	10644
2025 Q3	$270K	Sell	183,988 -51,666	-22%	-$76.8K	﹤0.01%	10594
2025 Q2	$419K	Sell	235,654 -109,803	-32%	-$163K	﹤0.01%	9041
2025 Q1	$504K	Buy	345,457 +162,834	+89%	+$318K	﹤0.01%	8459
2024 Q4	$279K	Buy	182,623 +65,543	+56%	+$107K	﹤0.01%	9799
2024 Q3	$212K	Buy	117,080 +116,316	+15,225%	+$212K	﹤0.01%	10023
2024 Q2	$1.28K	Sell	764 -103,829	-99%	-$216K	﹤0.01%	13840
2024 Q1	$270K	Buy	104,593 +84,650	+424%	+$197K	﹤0.01%	9700
2023 Q4	$39.5K	Buy	+19,943	New	+$17.4K	﹤0.01%	12028
2023 Q3	–	Sell	-2,563	Closed	-$2.82K	–	14347
2023 Q2	$2.92K	Buy	+2,563	New	+$2.23K	﹤0.01%	13737
2023 Q1	–	Sell	-215,367	Closed	-$154K	–	14781
2022 Q4	$154K	Sell	215,367 -881	-0.4%	-$768	﹤0.01%	10570
2022 Q3	$142K	Buy	216,248 +95,925	+80%	+$135K	﹤0.01%	10768
2022 Q2	$223K	Sell	120,323 -108,630	-47%	-$234K	﹤0.01%	10469
2022 Q1	$737K	Sell	228,953 -53,906	-19%	-$182K	﹤0.01%	8442
2021 Q4	$1.22M	Sell	282,859 -452,273	-62%	-$2.45M	﹤0.01%	7460
2021 Q3	$4.39M	Buy	735,132 +182,513	+33%	+$1.22M	﹤0.01%	4557
2021 Q2	$4.58M	Buy	552,619 +331,307	+150%	+$2.69M	﹤0.01%	4632
2021 Q1	$1.9M	Sell	221,312 -56,444	-20%	-$626K	﹤0.01%	6500
2020 Q4	$3.36M	Buy	277,756 +150,962	+119%	+$2.08M	﹤0.01%	4383
2020 Q3	$2.06M	Sell	126,794 -52,601	-29%	-$862K	﹤0.01%	4653
2020 Q2	$2.69M	Sell	179,395 -606,104	-77%	-$8.18M	﹤0.01%	4047
2020 Q1	$5.7M	Buy	+785,499	New	+$6.17M	﹤0.01%	2546
2019 Q3	–	Sell	-13,928	Closed	-$52.1K	–	9193
2019 Q2	$53K	Sell	13,928 -1,451	-9%	-$5.13K	﹤0.01%	8713
2019 Q1	$64K	Sell	15,379 -25,944	-63%	-$89K	﹤0.01%	8729
2018 Q4	$90K	Buy	41,323 +25,190	+156%	+$79.8K	﹤0.01%	8284
2018 Q3	$62K	Buy	+16,133	New	+$56.4K	﹤0.01%	8752
2018 Q2	–	Sell	-16,714	Closed	-$74K	–	8845
2018 Q1	$74K	Sell	16,714 -3,649	-18%	-$12.3K	﹤0.01%	7817
2017 Q4	$51K	Buy	+20,363	New	+$60.6K	﹤0.01%	7626
2017 Q2	–	Sell	-18,025	Closed	-$78K	–	7529
2017 Q1	$78K	Buy	+18,025	New	+$83.2K	﹤0.01%	6936
2016 Q3	–	Sell	-10,112	Closed	-$66K	–	7261
2016 Q2	$66K	Buy	+10,112	New	+$67.5K	﹤0.01%	6339
2016 Q1	–	Sell	-25,876	Closed	-$165K	–	6870
2015 Q4	$165K	Buy	25,876 +21,392	+477%	+$140K	﹤0.01%	6061
2015 Q3	$23K	Buy	4,484 +715	+19%	+$4.17K	﹤0.01%	8064
2015 Q2	$26K	Sell	3,769 -1,617	-30%	-$11.3K	﹤0.01%	8035
2015 Q1	$38K	Sell	5,386 -318	-6%	-$2.6K	﹤0.01%	7557
2014 Q4	$48K	Sell	5,704 -295	-5%	-$2.27K	﹤0.01%	7222
2014 Q3	$51K	Buy	5,999 +850	+17%	+$7.54K	﹤0.01%	6890
2014 Q2	$46K	Sell	5,149 -206,996	-98%	-$1.86M	﹤0.01%	6792
2014 Q1	$2.23M	Buy	+212,145	New	+$2.34M	﹤0.01%	2537

Other funds holding CGEN

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

YLHM

Yelin Lapidot Holdings Management Tel Aviv, Israel $480M AUM 42.17% 1-Year Est. Return

Citadel Advisors's CGEN Position: Q1 2026 in Review

Citadel Advisors reduced its Compugen (CGEN) stake by 28% in Q1 2026, selling an estimated $86.8K and leaving 112,393 shares worth $239K. The position accounts for ﹤0.01% of the portfolio, ranked #11013.

Citadel Advisors first reported a position in CGEN in Q1 2014 and has held it in 39 quarters since. The position peaked at $5.7M in Q1 2020. 78 funds tracked by Wall St. Rank hold CGEN as of Q1 2026.

Citadel Advisors held 112,393 shares of Compugen worth $239K as of Q1 2026.
Citadel Advisors sold 44,722 Compugen shares in Q1 2026, an estimated $86.8K.
Compugen made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #11013 holding.
Citadel Advisors first reported a position in Compugen in Q1 2014 and has held it in 39 quarters since.
Citadel Advisors's Compugen position peaked at $5.7M in Q1 2020.
78 funds tracked by Wall St. Rank held Compugen as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.